Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 391 results for "sun pharma advanced research"

40 images for sun pharma advanced research, 1 month ago
New Indian Express, 1 month ago
BioSpace, 1 week ago, 2 weeks ago, 2 weeks ago
PharmaVOICE, 1 month ago
International Business Times India, 1 month ago
Yahoo! News, 1 month ago
Yahoo! UK and Ireland, 1 month ago, 1 month ago

USFDA subjects SPARC Xelpros nod to 'satisfactory resolution'

Sun Pharma Advanced Research Company today said the US health regulator has not approved its new drug application for Xelpros, a preservative-free eye drop. "The company has received a Complete Response Letter (CRL) from USFDA for the new drug ...
 Business Standard1 month ago USFDA nod for SPARC Xelpros tied to resolution of Halol plant deficiencies  Business Line1 month ago US Drug Regulator Subjects SPARC Xelpros Nod To 'Satisfactory Resolution'  NDTV1 month ago

Sell Dabur, Vedanta; buy Sun Pharma Advanced Research: Gujral

Ashwani Gujral of is of the view that one may sell Dabur India and Vedanta and buy Sun Pharma Advance Research Company.
 Money Control1 month ago Sell Marico, buy Sun Pharma Advanced Research: Mitesh Thacker  Money Control2 months ago

SUN PHARMA ADVANCED RESEARCH : No usfda approval to sparc's xelpros yet

Sun Pharma Advanced Research Company (SPARC) has stated that the US Food and Drug Administration (USFDA) has not cleared its new drug application (NDA) for Xelpros, a preservative-free eyedrop. USFDA has issued a complete response letter (CRL) to ...
 4 Traders1 month ago SPARC advances over 6% on getting USFDA's CRL for Xelpros  Economic Times1 month ago NO USFDA APPROVAL TO SPARC'S XELPROS YET  Pharmacy Choice1 month ago

Did Sun Pharma arm pay clinical trial workers in recalled notes?

In a major embarrassment to India Inc, the countrys largest drug-maker Sun Pharmaceuticals research arm, Sun Pharma Advanced Research, allegedly paid its clinical research workers in demonetised 500 notes. A sting operation telecast by a local TV news channel ...
 Business Line1 month ago

Sun Pharma advances 1.4%; to acquire Biosintez in Russia is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we ...
 India Infoline2 months ago

Top 5 Vendors in the Global Active Pharmaceutical Ingredients Market from 2017 to 2021: Technavio

Technavio publishes a new market research report on the global active pharmaceutical ingredients market from 2017-2021. (Graphic: Business Wire) Multimedia Gallery URLMore LONDON--(BUSINESS WIRE)-- Technavio has announced the top five leading ...
 Yahoo! Finance1 month ago

Sweeping Generalizations About Safety of Genetically Modified Goods Not Fair

Genetically modified organisms (GMO) are widely used in scientific research and to produce goods other than food. Sweeping generalizations about safety of GMOs are "not fair", an eminent scientist said. On the GM Mustard controversy, Dinakar M.
 MedIndia6 days ago Sweeping generalisations about GMO not fair  ProKerala.com6 days ago 'Sweeping generalisations about GMO not fair'  Oneindia6 days ago

Sensex higher, Midcap corrects; pharma, FMCG, metals stocks slip

Benchmark indices gained for third consecutive session amid volatility, with the Nifty hovering around 8400 level. Technology, infra and private banks continued to support the market whereas pharma, FMCG and metals stocks were under pressure. 10:00 ...
 Moneycontrol.com1 week ago

Sun Pharma buys skin cancer drug Odomzo for $175 mn from Novartis

Sun Pharmaceutical Industries has acquired skin cancer drug Odomzo from Swiss giant Novartis for $175 million (nearly Rs 1,200 crore) as it looks to grow its speciality drug portfolio. The transaction gives Sun Pharma its first branded oncology ...
 Smart Investor1 month ago Sun Pharma steps up specialty biz, acquires cancer drug in $175 mn deal  Smart Investor1 month ago Sun Pharmaceutical to buy cancer drug from Novartis  Nikkei Asian Review1 month ago Sun Pharma Buys Novartis Anti-cancer Brand Odomzo For $175 Million  Businessworld India1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less